LYNPARZA Tablets 100 mg, 150mg General Drug Use-results Study in Patients on Maintenance Treatment After Platinum-based Chemotherapy for BRCA Mutated Curatively Unresectable Pancreas Cancer
Latest Information Update: 18 Jul 2024
At a glance
- Drugs Olaparib (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 09 Jul 2024 Status changed from recruiting to active, no longer recruiting.
- 31 May 2021 Status changed from not yet recruiting to recruiting.
- 21 May 2021 New trial record